Welcome to our dedicated page for Personalis SEC filings (Ticker: PSNL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Personalis, Inc. (NASDAQ: PSNL) SEC filings page provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents offer detailed information on Personalis’ financial performance, material agreements, reimbursement developments, and other events relevant to its precision oncology and medical laboratories business.
Form 8-K filings for Personalis frequently report material events such as quarterly and annual financial results, preliminary performance updates, and significant business milestones. Examples include 8-Ks furnishing press releases on results of operations and financial condition, and filings describing Medicare coverage determinations and reimbursement rates for the company’s ultrasensitive NeXT Personal MRD tests used in breast cancer recurrence surveillance.
Other 8-K filings detail material agreements, such as amendments to the commercialization and reference laboratory agreement with Tempus AI, Inc. Under that agreement, Tempus is authorized to market NeXT Personal in indications including breast cancer, lung cancer, immuno-oncology monitoring, and colorectal cancer, with specified exclusivity periods and standstill provisions. These filings help investors understand how Personalis structures partnerships around its tumor-informed MRD platform.
Through its periodic reports and current reports, Personalis discloses revenue composition across pharma tests and services, enterprise sales, population sequencing, clinical diagnostic revenue, and other categories, as well as information on cash, investments, and stockholders’ equity. Securities registration details in the filings confirm that Personalis’ common stock trades on The Nasdaq Global Market under the symbol PSNL.
On Stock Titan, SEC documents for PSNL are updated from EDGAR in near real time. AI-powered tools can summarize lengthy filings, highlight key items such as Medicare coverage changes, material agreements, and revenue breakdowns, and help users quickly locate information on topics like MRD reimbursement, commercialization partnerships, and capital structure without reading every page manually.